Do you have time to read all of the literature and figure out what’s best and what’s over-hyped?
The Hayes Knowledge Center is your solution when you need unbiased information about the impact of health technologies on patient safety and clinical outcomes, or to develop defensible, transparent coverage policies.
I am looking for…
Quality over quantity of evidence
Hayes reports focus on the quality of the body of evidence, not just the quantity. And even when evidence is limited, we include concise summaries of:
- Regulatory status as well as reported recall and adverse events
- Reimbursement, coding and health economic information
- Publicly available best practice guidelines
More than just a database of reports!
Every Hayes client receives support from real nurses who understand your clinical questions and can assist you finding the answers you need. They become an extension of your team, helping you solve your problems.
No matter what the question or project, we can help address the questions you are confronted with, using evidence as the foundation of any decision. It’s our goal to help solve your problems, overcome hurdles and choose the right path.
So, what is a “medical technology”?
Medical technologies include: diagnostic and screening tests, including genetic tests; imaging procedures; medical, surgical, or dental health devices, services or procedures; behavioral and mental health interventions; drugs or biologics; preventive or wellness strategies; public health programs; or health information technologies.
The Hayes Knowledge Center includes access to a variety of reports from Hayes, including:
Medical Technology Directory
Comprehensive Health Technology Assessments (HTAs) evaluating medical technologies for which there are a number of published clinical trials and a substantial body of evidence. These reports include the Hayes Rating (an overall rating of the strength and direction of the body of evidence for the technology). Directory reports are intended to support the development of coverage policy and evidence-based clinical practices. They may include:
- Standard HTAs: Assess the benefits and harms of a single device, drug, biologic, test or treatment.
- Comparative Effectiveness Review (CER): Assess the relative benefits and harms of two or more devices, drugs, biologics, tests or treatments.
Health Technology Brief
HTAs that address a wide variety of health technologies, with a focus on emerging technologies that are in the early stages of dissemination or existing technologies that are being used for new applications and for which there is a limited body of peer-reviewed, published evidence. These HTAs offer a critical analysis of available evidence, including clinical trial data, along with information regarding safety issues, coverage policies from the private and public sectors, regulatory approvals, consensus statements, and an overall projection of the potential clinical efficacy and economic impact of the technology.
Genetic Test Evaluation
Genetic Test Evaluation reports are comprehensive HTAs of genetic tests across a range of conditions and applications. Each report provides a clear, objective view of the science behind a specific genetic test, the clinical evidence supporting the test, the testing laboratories involved, an explanation of how the test is used in clinical practice, appropriate patient selection criteria, and the likelihood of reimbursement for each type of test.
Search & Summary
Non-analytical reports generated in response to client requests for specific information about technologies that have not already been addressed in other Hayes reports. Each Search & Summary report describes findings from focused searches of MEDLINE and other National Library of Medicine (NLM) databases, Embase, and regulatory databases. Relevant abstracts from English-language, peer-reviewed clinical trials, and review articles on the topic are provided in the report, along with all available information related to applicable regulatory approvals and national coverage determinations by CMS for a specific technology and major private payers, as well as links to high-quality online information sources.